What are potential barriers and enablers to patient and physician participation in Canadian cell therapy trials for stroke? A stakeholder interview study
Dean A Fergusson,
Dar Dowlatshahi,
Manoj M Lalu,
Justin Presseau,
Gisell Castillo,
Madison Foster,
Analyssa Cardenas,
Whitney Tam,
Jennifer Zlepnig,
Deborah Timpson,
Pascale Juneau
Affiliations
Dean A Fergusson
Epidemiology Program, Ottawa Hospital Research Institute, Ottawa, Ontario, Canada
Dar Dowlatshahi
Department of Medicine, Division of Neurology and Ottawa Hospital Research Institute, University of Ottawa, Ottawa, Ontario, Canada
Manoj M Lalu
associate scientist and assistant professor
Justin Presseau
Blueprint Translational Research Group, Ottawa Hospital Research Institute, Ottawa, Ontario, Canada
Gisell Castillo
Blueprint Translational Research Group, Ottawa Hospital Research Institute, Ottawa, Ontario, Canada
Madison Foster
Blueprint Translational Research Group, Ottawa Hospital Research Institute, Ottawa, Ontario, Canada
Analyssa Cardenas
Clinical Epidemiology Program, Blueprint Translational Research Group, Ottawa Hospital Research Institute, Ottawa, Ontario, Canada
Whitney Tam
Clinical Epidemiology Program, Blueprint Translational Research Group, Ottawa Hospital Research Institute, Ottawa, Ontario, Canada
Jennifer Zlepnig
Faculty of Medicine, University of Ottawa, Ottawa, Ontario, Canada
Deborah Timpson
Department of Rehabilitation, Pembroke Regional Hospital, Pembroke, Ontario, Canada
Pascale Juneau
Clinical Epidemiology Program, Blueprint Translational Research Group, Ottawa Hospital Research Institute, Ottawa, Ontario, Canada
